October 26, 2017

Surescripts Responds to Public Health Emergency Declaration for Opioid Epidemic

Surescripts supports the federal declaration of the opioid epidemic as a public health emergency. This action will provide additional resources and increased urgency to assist in our collective response to the crisis. The opioid epidemic has killed thousands of Americans, and costs our nation billions of dollars in unnecessary health and social costs each year. As the nation’s health information network, we exist to increase patient safety, lower costs and ensure quality care. We have been focused on addressing the opioid epidemic for many years. And we remain committed to our work in collaboration with the federal government as well as state and local officials, and our network partners, who are on the ground dealing with this epidemic in communities across the country. 

The good news is that technology exists today to help providers make the best-informed care decisions for patients who may be at risk of abuse or overdose. Whether that’s with electronic prescribing of controlled substances to eliminate paper prescriptions that can be stolen or forged, access to a patient’s prescription history to identify potential overuse or abuse, and sharing of care location information that can help identify potential “doctor shopping.” While we’ve seen substantial progress in some areas, with more than 45 million controlled substance prescriptions delivered electronically last year, more work is needed to drive adoption and utilization of these technologies nationwide. In New York, where electronic prescribing of controlled substances is mandated, nearly all prescriptions are delivered electronically. But nationwide, that number stands at just 14 percent. Another ten states are implementing or considering laws to help drive greater adoption and utilization of electronic prescribing of controlled substances, and we support the adoption of the federal EPCS Act into law in order to drive the same level of progress nationally.

YOU MIGHT ALSO LIKE

April 03, 2018

Surescripts to the Food and Drug Administration: Tap into Tech to Hinder Opioid Misuse and Diversion

As the nation’s policy makers grapple with how to curb the opioid epidemic, we at Surescripts continue to join the conversation at various forums and offer our assistance and expertise in support of the cause. Read more...

March 14, 2018

Surescripts Commends Congressional Leadership as EPCS Act Gains Traction in Senate, Following House Bill

In a letter presented to the U.S. Senate on February 27, Surescripts expressed strong support for the Every Prescription Conveyed Securely (EPCS) Act, and thanked the policymakers who have championed this important bi-partisan bill. The letter was submitted for the record the same day the bill was introduced to the Senate. Read more...

January 24, 2018

Surescripts Supports the AMA’s Work to Reduce Barriers to EPCS

The American Medical Association (AMA), the nation’s largest association of physicians and medical students, is working to reduce barriers to the implementation of electronic prescribing of controlled substances (EPCS), as stated at its 2017 AMA Interim Meeting in Honolulu. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX